SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-002739
Filing Date
2015-08-14
Accepted
2015-08-14 16:30:53
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fpmi10q_june302015.htm 10-Q 555669
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARB ex31-1.htm EX-31.1 16631
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARB ex31-2.htm EX-31.2 16738
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO U.S.C. SECTION 1350 AS ex32-1.htm EX-32.1 5778
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO U.S.C. SECTION 1350 AS ex32-2.htm EX-32.2 5810
  Complete submission text file 0001415889-15-002739.txt   2568874

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fpmi-20150630.xml EX-101.INS 298206
7 XBRL TAXONOMY EXTENSION SCHEMA fpmi-20150630.xsd EX-101.SCH 29530
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fpmi-20150630_cal.xml EX-101.CAL 37742
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fpmi-20150630_def.xml EX-101.DEF 131984
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fpmi-20150630_lab.xml EX-101.LAB 224659
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fpmi-20150630_pre.xml EX-101.PRE 186330
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-147193 | Film No.: 151056348
SIC: 2835 In Vitro & In Vivo Diagnostic Substances